Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.

Florenzo IannoneFausto SalaffiMarco FornaroMarco Di CarloStefano GentileschiLuca CantariniGiuseppe Lopalco

Published in: European journal of clinical investigation (2018)

This study provided evidence that baseline mRDCI negatively impacts the persistence on biologic treatments and clinical outcomes in patients with RA, SpA and PsA in real-life settings.

Keyphrases

rheumatoid arthritis
disease activity
ankylosing spondylitis
prostate cancer
interstitial lung disease
randomized controlled trial
systematic review
emergency department
radical prostatectomy
adverse drug
idiopathic pulmonary fibrosis